Selected country: NIGER < change/back to search

Explore the key typhoid vaccination cost-effectiveness results as well as the specific inputs and outputs of the analysis for Niger below.

Expand the "Parameters" box to explore the influence of different inputs. For example, MDR/XDR typhoid may require more expensive treatment, and therefore the prevalence of antimicrobial resistant (AMR) typhoid could impact on TCV cost-effectiveness. This is one of the parameters that can be updated below based on local insight.